Home › Funds › Nan Fung Group Holdings Ltd › LBRX

Nan Fung Group Holdings Ltd position in LBRX

LB PHARMACEUTICALS INC · Health Care

Nan Fung Group Holdings Ltd reported holding 630,657 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 16.35% of its reported portfolio and ranking #1 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)630.66K sh
Reported value held$24.20M
Portfolio Weight16.35%
First reportedQ3 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nan Fung Group Holdings Ltd's LBRX position evolved

Nan Fung Group Holdings Ltd first disclosed a stake in LBRX in Q3 2025 at 300,000 shares (US$4.7M). The position peaked in Q3 2026 at 630,657 shares, worth US$24.2M. Across 5 filings, Nan Fung Group Holdings Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 630,657 shares valued at US$24.2M. Notable position changes include a 110% increase in Q1 2026 (shares rose 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 300.00K $4.74M New
Q4 2025 300.00K $6.68M Hold
Q1 2026 630.66K $15.55M Add
Q2 2026 630.66K $20.47M Hold
Q3 2026 630.66K $24.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 106 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has Nan Fung Group Holdings Ltd held LBRX?

Nan Fung Group Holdings Ltd has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Nan Fung Group Holdings Ltd's current position in LBRX?

As of Q3 2026, Nan Fung Group Holdings Ltd holds 630.66K shares of LBRX (LB PHARMACEUTICALS INC), valued at $24.20M, representing 16.35% of its reported portfolio and ranking #1.

Has Nan Fung Group Holdings Ltd been buying or selling LBRX?

In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in LBRX. The position peaked in Q3 2026 at 630.66K shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 106 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.